ORIGINAL RESEARCH article

Front. Epidemiol.

Sec. Infectious Disease Epidemiology

Volume 5 - 2025 | doi: 10.3389/fepid.2025.1578951

Molecular epidemiology of influenza, respiratory syncytial virus, SARS-CoV-2, other respiratory viruses and bacteria in children two-year-old and under in West Bengal: A one-year influenza-like illness surveillance study in two hospitals

Provisionally accepted
Tila  KhanTila Khan1*Sayantan  HalderSayantan Halder1Ranjan  Saurav DasRanjan Saurav Das1Abhishek  JaiswalAbhishek Jaiswal2Pearl  Helena Scott LeoPearl Helena Scott Leo2Arabinda  MahatoArabinda Mahato3Tarapada  GhoshTarapada Ghosh2Parthasarathi  SatpathiParthasarathi Satpathi2Sangeeta  Das BhattacharyaSangeeta Das Bhattacharya4
  • 1Indian Institute of Technology Kharagpur, Kharagpur, India
  • 2Midnapore Medical College and Hospital, Medinīpur, India
  • 3Kharagpur Sub Divisional Hospital, Kharagpur, India
  • 4Christiana Care Health System, Newark, United States

The final, formatted version of the article will be published soon.

BackgroundLower respiratory infections are the leading cause of paediatric morbidity and mortality. This study documents the incidence and etiology of influenza-like illness (ILI) among young children in rural eastern India.MethodsWe conducted a surveillance of ILI in children visiting paediatric clinics of two hospitals in District West Midnapore, West Bengal from April 1, 2022 to March 31, 2023. Nasopharyngeal swabs were collected from children 0-2 years of age with ILI and tested for influenza, respiratory syncytial virus (RSV), and SARS-CoV-2; a representative set for the respiratory panel.ResultsOf 9923 outpatient children 0-14 years of age screened, 1001 had ILI, of which 439 (44%) were in 0–2-year-olds. The ILI incidence was 439/4310 [10.2% (95% CI: 9.29-11.1)] in the 0-2-year-olds, 288/2473 [11.6% (10.4-12.9)] in >2-5-year-olds, and, 274/3140 [8.7% (7.7-9.7)] in >5-14-year-olds. Of 390 enrolled children (median age: 12 months), viruses were identified in 23.3%, occurring singly (15%) or with other viruses (1.3%). RSV was the most common virus (12.6%), followed by influenza (6.6%) and SARS-CoV-2 (0.77%). Influenza subtypes included IA/H3 (50%), IA/H1N1pdm2009 (34.6%) and IB (15.4%). IA/H1N1pdm09 predominated during the 2022 monsoon, RSV during 2022 autumn and A/H3 and B during 2023 winters. Cough and difficulty breathing were associated with RSV.The major bacteria detected were Streptococcus pneumoniae (55.5%), Haemophilus influenzae (29%) and Moraxella catarrhalis (3.7%). Other viruses were parainfluenza virus 3 (4.4%), bocavirus (3.7%) and adenovirus (3%). Viral-bacterial co-detections were frequent (20%). Seventeen children required hospitalization, with difficulty breathing increasing hospitalization risk [OR=4.47, 95% CI=1.67-12]. Children with RSV had increased odds of hospitalization (OR=3.11, 95% CI: 1-9.26).ConclusionsThe majority of ILI was observed in children aged 0-2 years, with RSV and influenza as major viral causes associated with ILI. RSV increased the risk of hospitalization. These findings contribute to building the evidence base for maternal RSV immunization policy in India.

Keywords: Child, Infant, influenza, respiratory syncytial virus, SARS-CoV-2, Epidemiology, Respiratory Tract Infections, influenza-like illness

Received: 18 Feb 2025; Accepted: 29 Apr 2025.

Copyright: © 2025 Khan, Halder, Das, Jaiswal, Leo, Mahato, Ghosh, Satpathi and Bhattacharya. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Tila Khan, Indian Institute of Technology Kharagpur, Kharagpur, India

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.